+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Uveitis Treatment Market by Treatment Type (Biologics, Corticosteroids, Immunosuppressants), Administration Route (Intravitreal Injection, Systemic, Topical), Distribution Channel, End User, Uveitis Type - Global Forecast 2025-2030- Product Image
Uveitis Treatment Market by Treatment Type (Biologics, Corticosteroids, Immunosuppressants), Administration Route (Intravitreal Injection, Systemic, Topical), Distribution Channel, End User, Uveitis Type - Global Forecast 2025-2030- Product Image
Sale

Uveitis Treatment Market by Treatment Type (Biologics, Corticosteroids, Immunosuppressants), Administration Route (Intravitreal Injection, Systemic, Topical), Distribution Channel, End User, Uveitis Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888962
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior healthcare leaders navigating the complex landscape of ocular disease management are observing substantial shifts in the uveitis treatment market. As innovative therapeutic approaches gain traction and regulatory requirements evolve, a range of opportunities and challenges for sustainable growth and improved clinical outcomes is emerging.

Market Snapshot: Uveitis Treatment Market Growth and Outlook

The Uveitis Treatment Market grew from USD 783.24 million in 2024 to USD 852.20 million in 2025. It is expected to continue growing at a CAGR of 8.56%, reaching USD 1.28 billion by 2030. Momentum is being driven by increased adoption of biologics, notable regulatory adjustments, and expanding healthcare infrastructure, especially across emerging regions. Providers and industry stakeholders are adapting to new patient management needs and technology-driven care pathways, supporting the ongoing evolution of the uveitis ecosystem.

Scope & Detailed Segmentation of the Uveitis Treatment Market

  • Treatment Types: Biologics (including monoclonal antibodies such as Adalimumab, Infliximab), Corticosteroids (Dexamethasone, Prednisolone, Triamcinolone), Immunosuppressants (Azathioprine, Cyclosporine, Methotrexate)
  • Administration Routes: Intravitreal Injection, Systemic (Intravenous, Oral), Topical (Eye Drops, Ointments)
  • Distribution Channels: Hospital Pharmacy (Inpatient, Outpatient), Online Pharmacy (Branded, Generic), Retail Pharmacy (Chain, Independent)
  • End Users: Ambulatory Surgical Centers, Day Care Centers, Multispecialty Clinics, Ophthalmology Clinics, Government Hospitals, Private Hospitals
  • Uveitis Types: Anterior Uveitis, Intermediate Uveitis, Panuveitis, Posterior Uveitis
  • Regions Covered: Americas, Europe, Middle East & Africa, Asia-Pacific (including key submarkets by country)
  • Technologies: Sustained-release ocular implants, microinjection drug delivery, digital health integration, real-world data analytics
  • Key Companies: AbbVie Inc., Novartis AG, Alimera Sciences, Santen Pharmaceutical Co., Ltd., Bausch Health Companies Inc., Roche Holding AG, Eyepoint Pharmaceuticals, Apellis Pharmaceuticals, Clearside Biomedical, Oxurion NV

Key Takeaways for Senior Decision-Makers

  • Biologic therapies are redefining treatment protocols, shifting reliance from broad-spectrum anti-inflammatories toward targeted interventions with improved safety profiles.
  • Integrated diagnostic and drug delivery innovations enhance early detection and enable more consistent therapeutic efficacy, reducing the risk of vision loss.
  • Healthcare providers face evolving reimbursement models and must adapt to variable policy conditions that influence patient access and formulary decisions.
  • Regional variations—driven by infrastructure, regulatory environments, and payer requirements—necessitate highly tailored go-to-market and commercialization strategies.
  • Collaborative partnerships between established corporations and emerging biotechs drive continued innovation, portfolio expansion, and market differentiation.
  • Investment in digital health platforms, sustained-release technologies, and real-world evidence collection is critical to sustaining long-term competitive advantage.

Tariff Impact on Market Dynamics

Imposed US tariffs on key pharmaceutical imports have introduced procurement cost pressures throughout the uveitis treatment supply chain. Manufacturers are diversifying supplier networks and adjusting production strategies to minimize margin impact. Treatment providers must navigate these changing conditions, with some adaptation in inventory management and reimbursement plans. Mitigating tariff-related risks requires a focus on scenario planning and agile operational frameworks.

Methodology & Data Sources Supporting Market Insights

The report employs a rigorous multistage methodology, beginning with interviews spanning clinical, regulatory, and supply chain experts. Secondary research draws from journals, key regulatory filings, and white papers to validate market and technology trends. A triangulation process aligns primary and secondary findings, while desk research explores the innovation landscape, ensuring integrity across insights and recommendations.

Why This Report Matters for Business Strategy

  • Provides a framework for aligning R&D investments with emerging therapeutic opportunities, validated by granular stakeholder insights.
  • Guides operational agility through scenario-based recommendations for supply chain and procurement strategy in a fluctuating policy landscape.
  • Supports informed decision-making by highlighting technology adoption, shifting clinical practices, and regional commercialization levers.

Conclusion: Strategic Pathways for Sustained Market Leadership

The uveitis treatment market demands a strategic approach that integrates scientific, regulatory, and operational expertise. Ongoing monitoring, investment in real-world evidence, and collaborative partnerships are fundamental to meeting evolving needs. This report serves as a roadmap to support effective market positioning and better patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of biologic therapies targeting specific inflammatory pathways in non-infectious uveitis
5.2. Development of sustained-release intraocular steroid implants to reduce injection frequency in chronic uveitis
5.3. Emergence of personalized medicine approaches using biomarkers to predict uveitis flare-ups and treatment response
5.4. Rising clinical trials of novel small-molecule inhibitors aiming to target ocular immune cell migration in uveitis patients
5.5. Increased use of teleophthalmology platforms for remote monitoring and management of chronic uveitis patients in underserved areas
5.6. Strategic partnerships between biotech firms and academic institutions to accelerate uveitis drug discovery and translational research
5.7. Focus on developing gene therapy solutions targeting genetic mutations associated with hereditary forms of posterior uveitis
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Uveitis Treatment Market, by Treatment Type
8.1. Introduction
8.2. Biologics
8.2.1. Adalimumab
8.2.2. Infliximab
8.3. Corticosteroids
8.3.1. Dexamethasone
8.3.2. Prednisolone
8.3.3. Triamcinolone
8.4. Immunosuppressants
8.4.1. Azathioprine
8.4.2. Cyclosporine
8.4.3. Methotrexate
9. Uveitis Treatment Market, by Administration Route
9.1. Introduction
9.2. Intravitreal Injection
9.2.1. Bolus Injection
9.2.2. Sustained Release
9.3. Systemic
9.3.1. Intravenous
9.3.2. Oral
9.4. Topical
9.4.1. Eye Drops
9.4.2. Ointments
10. Uveitis Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.2.1. Inpatient Pharmacy
10.2.2. Outpatient Pharmacy
10.3. Online Pharmacy
10.3.1. Branded
10.3.2. Generic
10.4. Retail Pharmacy
10.4.1. Chain Pharmacy
10.4.2. Independent Pharmacy
11. Uveitis Treatment Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.2.1. Day Care Centers
11.3. Clinics
11.3.1. Multispecialty Clinics
11.3.2. Ophthalmology Clinics
11.4. Hospitals
11.4.1. Government Hospital
11.4.2. Private Hospital
12. Uveitis Treatment Market, by Uveitis Type
12.1. Introduction
12.2. Anterior Uveitis
12.3. Intermediate Uveitis
12.4. Panuveitis
12.5. Posterior Uveitis
13. Americas Uveitis Treatment Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Uveitis Treatment Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Uveitis Treatment Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AbbVie Inc.
16.3.2. Novartis AG
16.3.3. Alimera Sciences, Inc.
16.3.4. Santen Pharmaceutical Co., Ltd.
16.3.5. Bausch Health Companies Inc.
16.3.6. Roche Holding AG
16.3.7. Eyepoint Pharmaceuticals, Inc.
16.3.8. Apellis Pharmaceuticals, Inc.
16.3.9. Clearside Biomedical, Inc.
16.3.10. Oxurion NV
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. UVEITIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL UVEITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UVEITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. UVEITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. UVEITIS TREATMENT MARKET: RESEARCHAI
FIGURE 26. UVEITIS TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 27. UVEITIS TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 28. UVEITIS TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. UVEITIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL UVEITIS TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL UVEITIS TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ADALIMUMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ADALIMUMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INFLIXIMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INFLIXIMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY PREDNISOLONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY PREDNISOLONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TRIAMCINOLONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TRIAMCINOLONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY AZATHIOPRINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY AZATHIOPRINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CYCLOSPORINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CYCLOSPORINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY METHOTREXATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY METHOTREXATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY BOLUS INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY BOLUS INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY EYE DROPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INPATIENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INPATIENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY OUTPATIENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY OUTPATIENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DAY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY DAY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY MULTISPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY MULTISPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY GOVERNMENT HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY GOVERNMENT HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ANTERIOR UVEITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY ANTERIOR UVEITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INTERMEDIATE UVEITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY INTERMEDIATE UVEITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY PANUVEITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY POSTERIOR UVEITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL UVEITIS TREATMENT MARKET SIZE, BY POSTERIOR UVEITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS UVEITIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES UVEITIS TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 197. CANADA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 198. CANADA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 199. CANADA UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 200. CANADA UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 201. CANADA UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 202. CANADA UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 203. CANADA UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2024 (USD MILLION)
TABLE 204. CANADA UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2025-2030 (USD MILLION)
TABLE 205. CANADA UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 206. CANADA UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 207. CANADA UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, 2018-2024 (USD MILLION)
TABLE 208. CANADA UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, 2025-2030 (USD MILLION)
TABLE 209. CANADA UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 210. CANADA UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 211. CANADA UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 212. CANADA UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 213. CANADA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. CANADA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. CANADA UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 216. CANADA UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 217. CANADA UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 218. CANADA UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 219. CANADA UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 220. CANADA UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 221. CANADA UVEITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. CANADA UVEITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. CANADA UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 224. CANADA UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 225. CANADA UVEITIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 226. CANADA UVEITIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 227. CANADA UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 228. CANADA UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 229. CANADA UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2018-2024 (USD MILLION)
TABLE 230. CANADA UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2025-2030 (USD MILLION)
TABLE 231. MEXICO UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 232. MEXICO UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 233. MEXICO UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 234. MEXICO UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 235. MEXICO UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 236. MEXICO UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 237. MEXICO UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2024 (USD MILLION)
TABLE 238. MEXICO UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2025-2030 (USD MILLION)
TABLE 239. MEXICO UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 240. MEXICO UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 241. MEXICO UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, 2018-2024 (USD MILLION)
TABLE 242. MEXICO UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, 2025-2030 (USD MILLION)
TABLE 243. MEXICO UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 244. MEXICO UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 245. MEXICO UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 246. MEXICO UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 247. MEXICO UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. MEXICO UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. MEXICO UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 250. MEXICO UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 251. MEXICO UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 252. MEXICO UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 253. MEXICO UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 254. MEXICO UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 255. MEXICO UVEITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. MEXICO UVEITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. MEXICO UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 258. MEXICO UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 259. MEXICO UVEITIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 260. MEXICO UVEITIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 261. MEXICO UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 262. MEXICO UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 263. MEXICO UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2018-2024 (USD MILLION)
TABLE 264. MEXICO UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY INTRAVITREAL INJECTION, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 323. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 326. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 327. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 328. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 329. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 330. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 331. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2018-2024 (USD MILLION)
TABLE 332. ARGENTINA UVEITIS TREATMENT MARKET SIZE, BY UVEITIS TYPE, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2024 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2025-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA UVEITIS TREATMENT MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Uveitis Treatment market report include:
  • AbbVie Inc.
  • Novartis AG
  • Alimera Sciences, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Bausch Health Companies Inc.
  • Roche Holding AG
  • Eyepoint Pharmaceuticals, Inc.
  • Apellis Pharmaceuticals, Inc.
  • Clearside Biomedical, Inc.
  • Oxurion NV

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 852.2 Million
Forecasted Market Value ( USD ) by 2030 $ 1280 Million
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Anterior Uveitis Treatment Market by Treatment Type (Non Pharmacological, Pharmacological), Drug Class (Biologics, Corticosteroids, Immunosuppressants), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Anterior Uveitis Treatment Market by Treatment Type (Non Pharmacological, Pharmacological), Drug Class (Biologics, Corticosteroids, Immunosuppressants), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Uveitis Treatment Global Market Report 2025 - Product Image

Uveitis Treatment Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Uveitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Uveitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 190 Pages
  • Global
From
Anterior Uveitis Treatment - Global Strategic Business Report - Product Image

Anterior Uveitis Treatment - Global Strategic Business Report

  • Report
  • 383 Pages
  • Global
From
Uveitis Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Uveitis Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 135 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.